Opioid Maker to Pay for Overdose Antidote Development

Share this content:
Opioid Maker to Pay for Overdose Antidote Development
Opioid Maker to Pay for Overdose Antidote Development

THURSDAY, Sept. 6, 2018 (HealthDay News) -- A $3.4 million grant to help a non-profit company develop a less expensive opioid overdose antidote was announced by Purdue Pharma, which makes the opioid painkiller OxyContin.

The grant is being given to Pittsburgh-based Harm Reduction Therapeutics, which is trying to develop a low-cost nasal spray with the opioid overdose antidote naloxone.

Purdue is among a number of prescription opioid makers blamed for causing the United States' opioid addiction and overdose crisis, the Associated Press reported.

Purdue and other drug companies are being sued by local governments that claim the companies used deceptive marketing that encouraged doctors to overprescribe opioids, the AP reported. As of last week, opioid makers faced more than 1,000 lawsuits being overseen by a federal judge.

AP News Article
Purdue Pharma News Release

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »